PHARMACEUTICAL CONTAINING 6,7-DIHYDROPYRAZOLO [1,5-a]PYRAZINONE DERIVATIVE OR SALT THEREOF

To provide a pharmaceutical containing a compound that is useful as an agent for preventing and/or treating a disease associated with group IImGlu receptor.SOLUTION: An agent for treating and/or preventing schizophrenia comprises a compound of formula (1). Examples of the compound of formula (1) inc...

Full description

Saved in:
Bibliographic Details
Main Authors IKUMA YOHEI, FUKASAWA RYO, TOJO YASUTAKE, MASUMOTO HIDEJI
Format Patent
LanguageEnglish
Japanese
Published 27.06.2023
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:To provide a pharmaceutical containing a compound that is useful as an agent for preventing and/or treating a disease associated with group IImGlu receptor.SOLUTION: An agent for treating and/or preventing schizophrenia comprises a compound of formula (1). Examples of the compound of formula (1) include (7S)-3-(imidazo[1,2-a]pyridine-6-yl)-7-methyl-5-[4-(trifluoromethyl) phenyl]-6,7-dihydropyrazolo[1,5-a]pyrazine-4(5H)-one.SELECTED DRAWING: None 【課題】グループＩＩ ｍＧｌｕ受容体が関与する疾患の予防及び／又は治療剤として有用な化合物を含有する医薬を提供する。【解決手段】式（１）の化合物を含有する、統合失調症の治療剤及び又は予防剤である。TIFF2023089186000069.tif6077式（１）の化合物として、具体的には、例えば（７Ｓ）－３－（イミダゾ［１，２－ａ］ピリジン－６－イル）－７－メチル－５－［４－（トリフルオロメチル）フェニル］－６，７－ジヒドロピラゾロ［１，５－ａ］ピラジン－４（５Ｈ）－オンが示される。【選択図】なし
Bibliography:Application Number: JP20230066929